The DOI matches its Crossref record; 196 of the 196 references it cites were found in a registry or an index.
HTLV-1-associated myelopathy/tropical spastic paraparesis
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ANTIBODIES TO HUMAN T-LYMPHOTROPIC VIRUS TYPE-I IN PATIENTS WITH TROPICAL SPASTIC PARAPARESIS
Gessain, A., Vernant, J. C., Maurs, L., Barin, F., Gout, O., Calender, A., & De Thé, G. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92734-5 · Cited by 2,843
HTLV-I ASSOCIATED MYELOPATHY, A NEW CLINICAL ENTITY
Osame, M., Usuku, K., Izumo, S., Ijichi, N., Amitani, H., Igata, A., Matsumoto, M., & Tara, M. (1986) · The Lancet · doi:10.1016/s0140-6736(86)91298-5 · Cited by 2,404
Adult T-cell leukemia: clinical and hematologic features of 16 cases
Uchiyama, T., Yodoi, J., Sagawa, K., Takatsuki, K., & Uchino, H. (1977) · Blood · doi:10.1182/blood.v50.3.481.481 · Cited by 2,316
Epidemiological Aspects and World Distribution of HTLV-1 Infection
Gessain, A., & Cassar, O. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00388 · Cited by 1,428
Population Dynamics of Immune Responses to Persistent Viruses
Nowak, M. A., & Bangham, C. R. M. (1996) · Science · doi:10.1126/science.272.5258.74 · Cited by 1,277
Self-citationSpread of HTLV-I Between Lymphocytes by Virus-Induced Polarization of the Cytoskeleton
Igakura, T., Stinchcombe, J. C., Goon, P. K. C., Taylor, G. P., Weber, J. N., Griffiths, G. M., Tanaka, Y., Osame, M., & Bangham, C. R. M. (2003) · Science · doi:10.1126/science.1080115 · Cited by 755
Self-citationNagai, M., Usuku, K., Matsumoto, W., Kodama, D., Takenouchi, N., Moritoyo, T., Hashiguchi, S., Ichinose, M., Bangham, C. R., Izumo, S., et al. (1998) · Journal of Neurovirology · doi:10.3109/13550289809114225 · Cited by 694
Self-citationJacobson, S., Shida, H., McFarlin, D. E., Fauci, A. S., & Koenig, S. (1990) · Nature · doi:10.1038/348245a0 · Cited by 613
HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells
Satou, Y., Yasunaga, J.-I., Yoshida, M., & Matsuoka, M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507631103 · Cited by 593
Kägi, D., Ledermann, B., Bürki, K., Zinkernagel, R. M., & Hengartner, H. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.207 · Cited by 588
Moulin, D., Clark, A., Gilron, I., Ware, M., Watson, C., Sessle, B., Coderre, T., Morley-Forster, P., Stinson, J., Boulanger, A., et al. (2007) · Pain Research and Management · doi:10.1155/2007/730785 · Cited by 557
CHRONIC INFLAMMATORY ARTHROPATHY ASSOCIATED WITH HTLV-I
Nishioka, K., Maruyama, I., Sato, K., Kitajima, I., Nakajima, Y., & Osame, M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90038-x · Cited by 480
Multiple Viral Strategies of HTLV-1 for Dysregulation of Cell Growth Control
Yoshida, M. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.475 · Cited by 456
A comprehensive review: Krill Herd algorithm (KH) and its applications
Bolaji, A. L., Al-Betar, M. A., Awadallah, M. A., Khader, A. T., & Abualigah, L. M. (2016) · Applied Soft Computing · doi:10.1016/j.asoc.2016.08.041 · Cited by 443
Jeffery, K. J. M., Usuku, K., Hall, S. E., Matsumoto, W., Taylor, G. P., Procter, J., Bunce, M., Ogg, G. S., Welsh, K. I., Weber, J. N., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3848 · Cited by 419
Self-citationPrentice, C. R. M., & Forbes, C. D. (1974) · The Lancet · doi:10.1016/s0140-6736(74)91780-2 · Cited by 413
Kaplan, J. E., Osame, M., Kubota, H., Igata, A., Nishitani, H., Maeda, Y., KHABBAZ, R. F., & Janssen, R. S. (1990) · PubMed · Cited by 369
Pais-Correia, A.-M., Sachse, M., Guadagnini, S., Robbiati, V., Lasserre, R., Gessain, A., Gout, O., Alcover, A., & Thoulouze, M.-I. (2010) · Nature Medicine · doi:10.1038/nm.2065 · Cited by 344
HTLV-1 AND POLYMYOSITIS IN JAMAICA
Morgan, O. S., Mora, C., Rodgers-Johnson, P., & Char, G. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91793-5 · Cited by 337
Gillet, N. A., Malani, N., Melamed, A., Gormley, N., Carter, R., Bentley, D., Berry, C., Bushman, F. D., Taylor, G. P., & Bangham, C. R. M. (2011) · Blood · doi:10.1182/blood-2010-10-312926 · Cited by 316
Self-citationNakagawa, M., Izumo, S., Ijichi, S., Kubota, H., Arimura, K., Kawabata, M., & Osame, M. (1995) · Journal of Neurovirology · doi:10.3109/13550289509111010 · Cited by 316
Wattel, E., Vartanian, J. P., Pannetier, C., & Wain-Hobson, S. (1995) · Journal of Virology · doi:10.1128/jvi.69.5.2863-2868.1995 · Cited by 313
The mechanism of retroviral integration from X-ray structures of its key intermediates
Maertens, G. N., Hare, S., & Cherepanov, P. (2010) · Nature · doi:10.1038/nature09517 · Cited by 296
An HTLV-I Vaccine: Why, How, for Whom?
DE THÉ, G., & BOMFORD, R. (1993) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1993.9.381 · Cited by 272
Matsuoka, M., & Jeang, K.-T. (2011) · Oncogene · doi:10.1038/onc.2010.537 · Cited by 268
Nationwide survey of HTLV‐I–associated myelopathy in Japan: Association with blood transfusion
Osame, M., Janssen, R., Kubota, H., Nishitani, H., Igata, A., Nagataki, S., Mori, M., Goto, I., Shimabukuro, H., Khabbaz, R., et al. (1990) · Annals of Neurology · doi:10.1002/ana.410280110 · Cited by 268
Castro-Costa, C. M. D., Araújo, A. Q. C., Barreto, M. M., Takayanagui, O. M., Sohler, M. P., Silva, E. L. M. D., Paula, S. M. B. D., Ishak, R., Ribas, J. G. R., Rovirosa, L. C., et al. (2006) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2006.22.931 · Cited by 266
Self-citationAutoimmunity due to molecular mimicry as a cause of neurological disease
Levin, M. C., Lee, S. M., Kalume, F., Morcos, Y., Dohan, F. C., Hasty, K. A., Callaway, J. C., Zunt, J., Desiderio, D. M., & Stuart, J. M. (2002) · Nature Medicine · doi:10.1038/nm0502-509 · Cited by 264
Kannagi, M., Harada, S., Maruyama, I., Inoko, H., Igarashi, H., Kuwashima, G., Sato, S., Morita, M., Kidokoro, M., Sugimoto, M., et al. (1991) · International Immunology · doi:10.1093/intimm/3.8.761 · Cited by 253
Folks, T. M. (1991) · Virus Research · doi:10.1016/0168-1702(91)90100-a · Cited by 251
Manns, A., Wilks, R. J., Murphy, E. L., Haynes, G., Figueroa, J. P., Barnett, M., Hanchard, B., & Blattner, W. A. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910510609 · Cited by 245
Natural history of adult T-cell leukemia/lymphoma and approaches to therapy
Taylor, G. P., & Matsuoka, M. (2005) · Oncogene · doi:10.1038/sj.onc.1208979 · Cited by 223
Self-citationJeffery, K. J. M., Siddiqui, A. A., Bunce, M., Lloyd, A. L., Vine, A. M., Witkover, A. D., Izumo, S., Usuku, K., Welsh, K. I., Osame, M., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.12.7278 · Cited by 222
Self-citationSlattery, J. P., Franchini, G., & Gessain, A. (1999) · Genome Research · doi:10.1101/gr.9.6.525 · Cited by 220
The HTLV-1 neurological complex
Araujo, A. Q., & Silva, M. T. T. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70628-7 · Cited by 215
Self-citationUmehara, F., Izumo, S., Nakagawa, M., Ronquillo, A. T., Takahashi, K., Matsumuro, K., Sato, E., & Osame, M. (1993) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199307000-00010 · Cited by 214
Yamano, Y., & Sato, T. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00389 · Cited by 204
Self-citationHuman T-Lymphotropic Virus Type I (HTLV-I) Seroprevalence in Jamaica
Murphy, E., Figueroa, P., Gibbs, W. N., Holding-Cobham, M., Cranston, B., Malley, K., Bodner, A. J., Alexander, S. S., & Blattner, W. A. (1991) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115824 · Cited by 199
Selection Forces and Constraints on Retroviral Sequence Variation
Overbaugh, J., & Bangham, C. R. M. (2001) · Science · doi:10.1126/science.1059128 · Cited by 197
Self-citationCellular immune response to HTLV-1
Bangham, C. R. M., & Osame, M. (2005) · Oncogene · doi:10.1038/sj.onc.1208970 · Cited by 193
Self-citationBove, A. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i14.1555 · Cited by 188
Psychiatric Reports: Whether and How
(1966) · The Lancet · doi:10.1016/s0140-6736(66)90494-6 · Cited by 185
Prevalence and clinical features of HTLV neurologic disease in the HTLV Outcomes Study
Orland, J. R., Engstrom, J., Fridey, J., Sacher, R. A., Smith, J. W., Nass, C., Garratty, G., Newman, B., Smith, D., Wang, B., et al. (2003) · Neurology · doi:10.1212/01.wnl.0000096011.92542.da · Cited by 181
CLINICAL AND PATHOLOGICAL OBSERVATIONS ON JAMAICAN NEUROPATHY: A REPORT ON 206 CASES
MONTGOMERY, R. D., CRUICKSHANK, E. K., ROBERTSON, W. B., & MCMENEMEY, W. H. (1964) · Brain · doi:10.1093/brain/87.3.425 · Cited by 178
Lehky, T. J., Levin, M. C., Flerlage, N., Jacobson, S., Fox, C. H., Koenig, S., Izumo, S., Sato, E., Osame, M., & Raine, C. S. (1995) · Annals of Neurology · doi:10.1002/ana.410370206 · Cited by 175
Dorsher, P. T., & McIntosh, P. M. (2012) · Advances in Urology · doi:10.1155/2012/816274 · Cited by 174
Daenke, S., Nightingale, S., Cruickshank, J. K., & Bangham, C. R. (1990) · Journal of Virology · doi:10.1128/jvi.64.3.1278-1282.1990 · Cited by 173
Self-citationHINO, S. (2011) · Proceedings of the Japan Academy, Series B · doi:10.2183/pjab.87.152 · Cited by 170
HLA Class I Binding of HBZ Determines Outcome in HTLV-1 Infection
MacNamara, A., Rowan, A. G., Hilburn, S., Kadolsky, U. D., Fujiwara, H., Suemori, K., Yasukawa, M., Taylor, G. P., Bangham, C. R. M., & Asquith, B. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001117 · Cited by 168
Self-citationYamano, Y., Takenouchi, N., Li, H.-C., Tomaru, U., Yao, K., Grant, C. W., Maric, D. A., & Jacobson, S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200523913 · Cited by 168
Self-citationCTL quality and the control of human retroviral infections
Bangham, C. R. M. (2009) · European Journal of Immunology · doi:10.1002/eji.200939451 · Cited by 167
Self-citationBlocking LINGO-1 as a Therapy to Promote CNS Repair: From Concept to the Clinic
Mi, S., Blake Pepinsky, R., & Cadavid, D. (2013) · CNS Drugs · doi:10.1007/s40263-013-0068-8 · Cited by 167
Bove, A. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i36.4994 · Cited by 166
Izumo, S., Goto, I., Itoyama, Y., Okajima, T., Watanabe, S., Kuroda, Y., Araki, S., Mori, M., Nagataki, M., Matsukura, S., et al. (1996) · Neurology · doi:10.1212/wnl.46.4.1016 · Cited by 164
Komurian, F., Pelloquin, F., & de Thé, G. (1991) · Journal of Virology · doi:10.1128/jvi.65.7.3770-3778.1991 · Cited by 160
Nejmeddine, M., Barnard, A. L., Tanaka, Y., Taylor, G. P., & Bangham, C. R. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502639200 · Cited by 160
Self-citationFurukawa, Y., Yamashita, M., Usuku, K., Izumo, S., Nakagawa, M., & Osame, M. (2000) · The Journal of Infectious Diseases · doi:10.1086/315897 · Cited by 155
Immunopathogenesis of Human T Cell Lymphotropic Virus Type I–Associated Neurologic Disease
Jacobson, S. (2002) · The Journal of Infectious Diseases · doi:10.1086/344269 · Cited by 152
Therapeutic trials in 200 patients with HTLV-Iassociated myelopathy/tropical spastic paraparesis
Nakagawa, M., Nakahara, K., Maruyama, Y., Kawabata, M., Higuchi, I., Kubota, H., Izumo, S., Arimura, K., & Osame, M. (1996) · Journal of Neurovirology · doi:10.3109/13550289609146899 · Cited by 150
Toulza, F., Heaps, A. G., Tanaka, Y., Taylor, G. P., & Bangham, C. R. M. (2007) · Blood · doi:10.1182/blood-2007-10-118539 · Cited by 148
Self-citationArisawa, K., Soda, M., Endo, S., Kurokawa, K., Katamine, S., Shimokawa, I., Koba, T., Takahashi, T., Saito, H., Doi, H., et al. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000201)85:3<319::aid-ijc4>3.0.co;2-b · Cited by 148
Symptom Profiles Differ in Patients With Neuropathic Versus Non-neuropathic Pain
Dworkin, R. H., Jensen, M. P., Gammaitoni, A. R., Olaleye, D. O., & Galer, B. S. (2006) · Journal of Pain · doi:10.1016/j.jpain.2006.06.005 · Cited by 145
Donegan, E. A., Lee, H. M., Operskalski, E. A., Shaw, G. M., Kleinman, S. H., Busch, M. P., Stevens, C. E., Schiff, E. R., Nowicki, M. J., Hollingsworth, C. G., et al. (1994) · Transfusion · doi:10.1046/j.1537-2995.1994.34694295061.x · Cited by 145
Maloney, E. M., Cleghorn, F. R., Morgan, O. C., Rodgers‐Johnson, P., Cranston, B., Jack, N., Blattner, W. A., Bartholomew, C., & Manns, A. (1998) · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · doi:10.1097/00042560-199802010-00011 · Cited by 142
Mechanisms of HTLV-1 persistence and transformation
Boxus, M., & Willems, L. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605345 · Cited by 141
Toro, C., Rodés, B., Poveda, E., & Soriano, V. (2003) · Transplantation · doi:10.1097/00007890-200301150-00019 · Cited by 139
Neurogenesis and brain injury: managing a renewable resource for repair
Hallbergson, A. F., Gnatenco, C., & Peterson, D. A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci20098 · Cited by 138
Mochizuki, M., Watanabe, T., Yamaguchi, K., Tajima, K., Yoshimura, K., Nakashima, S., Shirao, M., Araki, S., Miyata, N., Mori, S., et al. (1992) · The Journal of Infectious Diseases · doi:10.1093/infdis/166.4.943 · Cited by 137
HTLV-associated myelopathy in a cohort of HTLV-I and HTLV-II-infected blood donors
Murphy, E. L., Fridey, J. L., Smith, J. W., Engstrom, J. W., Sacher, R. A., Miller, K., Gibble, J. W., Stevens, J. M., Thomson, R. A., Hansma, D., et al. (1997) · Neurology · doi:10.1212/wnl.48.2.315 · Cited by 137
Pharmacologic Management of Chronic Low Back Pain: Synthesis of the Evidence
White, A. P., Arnold, P. M., Norvell, D. C., Ecker, E. D., & Fehlings, M. G. (2011) · Spine · doi:10.1097/brs.0b013e31822f178f · Cited by 133
HTLV-1–infected T cells contain a single integrated provirus in natural infection
Cook, L. B. M., Rowan, A. G., Melamed, A., Taylor, G. P., & Bangham, C. R. M. (2012) · Blood · doi:10.1182/blood-2012-07-445593 · Cited by 125
Self-citationHTLV-1 induces a Th1-like state in CD4+CCR4+ T cells
Araya, N., Sato, T., Ando, H., Tomaru, U., Yoshida, M., Coler-Reilly, A. L. G., Yagishita, N., Yamauchi, J., Hasegawa, A., Kannagi, M., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci75250 · Cited by 123
Self-citationTattermusch, S., Skinner, J. A., Chaussabel, D., Banchereau, J., Berry, M. P. R., McNab, F. W., O’Garra, A., Taylor, G. P., & Bangham, C. R. M. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002480 · Cited by 122
Self-citationHTLV-1 clonality in adult T-cell leukaemia and non-malignant HTLV-1 infection
Bangham, C. R. M., Cook, L. B. M., & Melamed, A. (2013) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.11.003 · Cited by 119
Self-citationTaylor, G. P., Goon, P., Furukawa, Y., Green, H., Barfield, A., Mosley, A., Nose, H., Babiker, A., Rudge, P., Usuku, K., et al. (2006) · Retrovirology · doi:10.1186/1742-4690-3-63 · Cited by 117
Self-citationMelamed, A., Laydon, D. J., Gillet, N. A., Tanaka, Y., Taylor, G. P., & Bangham, C. R. M. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003271 · Cited by 117
Self-citationIjichi, S., Izumo, S., Eiraku, N., Machigashira, K., Kubota, R., Nagai, M., Ikegami, N., Kashio, N., Umehara, F., Maruyama, I., et al. (1993) · Medical Hypotheses · doi:10.1016/0306-9877(93)90111-3 · Cited by 115
Matsuoka, M., & Yasunaga, J. (2013) · Current Opinion in Virology · doi:10.1016/j.coviro.2013.08.010 · Cited by 115
Barnard, A. L., Igakura, T., Tanaka, Y., Taylor, G. P., & Bangham, C. R. M. (2005) · Blood · doi:10.1182/blood-2004-07-2850 · Cited by 114
Self-citationPositive feedback loop via astrocytes causes chronic inflammation in virus-associated myelopathy
Ando, H., Sato, T., Tomaru, U., Yoshida, M., Utsunomiya, A., Yamauchi, J., Araya, N., Yagishita, N., Coler-Reilly, A. L. G., Shimizu, Y., et al. (2013) · Brain · doi:10.1093/brain/awt183 · Cited by 113
Self-citationBlattner, W. A. (1990) · Raven Press eBooks · Cited by 112
Sato, T., Coler-Reilly, A. L. G., Utsunomiya, A., Araya, N., Yagishita, N., Ando, H., Yamauchi, J., Inoue, E., Ueno, T., Hasegawa, Y., et al. (2013) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002479 · Cited by 112
Self-citationFurukawa, Y., Fujisawa, J., Osame, M., Toita, M., Sonoda, S., Kubota, R., Ijichi, S., & Yoshida, M. (1992) · Blood · doi:10.1182/blood.v80.4.1012.1012 · Cited by 111
Human T-Lymphotropic Virus-1 Visualized at the Virological Synapse by Electron Tomography
Majorovits, E., Nejmeddine, M., Tanaka, Y., Taylor, G. P., Fuller, S. D., & Bangham, C. R. M. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002251 · Cited by 110
Self-citationNatural History of Human T-Lymphotropic Virus 1–Associated Myelopathy
Olindo, S., Cabre, P., Lézin, A., Merle, H., Saint-Vil, M., Signaté, A., Bonnan, M., Chalon, A., Magnani, L., Césaire, R., et al. (2006) · Archives of Neurology · doi:10.1001/archneur.63.11.1560 · Cited by 110
Vine, A. M., Witkover, A., Lloyd, A. L., Jeffery, K. J., Siddiqui, A. A., Marshall, S. E., Bunce, M., Eiraku, N., Izumo, S., Usuku, K., et al. (2002) · The Journal of Infectious Diseases · doi:10.1086/342953 · Cited by 105
Self-citationGenetic susceptibility to infectious diseases
Burgner, D. P., & Levin, M. (2003) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200301000-00002 · Cited by 103
Aye, M. M., Matsuoka, E., Moritoyo, T., Umehara, F., Suehara, M., Hokezu, Y., Yamanaka, H., Isashiki, Y., Osame, M., & Izumo, S. (2000) · Acta Neuropathologica · doi:10.1007/s004019900170 · Cited by 102
Transmission of Human T-Lymphotropic Virus Types I and II by Blood Transfusion
Sullivan, M. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.1991.00400100115019 · Cited by 102
Vandamme, A., Liu, H., Goubau, P., & Desmyter, J. (1994) · Virology · doi:10.1006/viro.1994.1337 · Cited by 102
Gotuzzo, E., Cabrera, J., Deza, L. M. R. D. L. C., Verdonck, K., Vandamme, A., CAIRAMPOMA, R., Vizcarra, D., Cabada, M. M., Narvarte, G., & Casas, C. D. L. (2004) · Clinical Infectious Diseases · doi:10.1086/423957 · Cited by 101
Goon, P. K. C., Biancardi, A., Fast, N. M., Igakura, T., Hanon, E., Mosley, A. J., Asquith, B., Gould, K. G., Marshall, S. E., Taylor, G. P., et al. (2004) · The Journal of Infectious Diseases · doi:10.1086/420832 · Cited by 100
Self-citationDemontis, M. A., Hilburn, S., & Taylor, G. P. (2012) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2012.0132 · Cited by 99
Self-citationGoon, P. K. C., Hanon, E., Igakura, T., Tanaka, Y., Weber, J. N., Taylor, G. P., & Bangham, C. R. M. (2002) · Blood · doi:10.1182/blood.v99.9.3335 · Cited by 98
Self-citationLézin, A., Olindo, S., Olière, S., Varrin‐Doyer, M., Marlin, R., Cabre, P., Smadja, D., & Césaire, R. (2005) · The Journal of Infectious Diseases · doi:10.1086/429962 · Cited by 97
HTLV-1 bZIP Factor Induces Inflammation through Labile Foxp3 Expression
Yamamoto-Taguchi, N., Satou, Y., Miyazato, P., Ohshima, K., Nakagawa, M., Katagiri, K., Kinashi, T., & Matsuoka, M. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003630 · Cited by 95
Lézin, A., Gillet, N. A., Olindo, S., Signaté, A., Grandvaux, N., Verlaeten, O., Belrose, G., Bittencourt, M. D. C., Hiscott, J. B., Asquith, B., et al. (2007) · Blood · doi:10.1182/blood-2007-04-085076 · Cited by 95
Hanon, E., Goon, P. K. C., Taylor, G. P., Hasegawa, H., Tanaka, Y., Weber, J. N., & Bangham, C. R. M. (2001) · Blood · doi:10.1182/blood.v98.3.721 · Cited by 89
Self-citationQuantification of HTLV-1 Clonality and TCR Diversity
Laydon, D. J., Melamed, A., Sim, A., Gillet, N. A., Sim, K., Darko, S. W., Kroll, J. S., Douek, D. C., Price, D. A., Bangham, C. R. M., et al. (2014) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003646 · Cited by 88
Self-citationNeurogenesis and brain injury: managing a renewable resource for repair
Hallbergson, A. F., Gnatenco, C., & Peterson, D. A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200320098 · Cited by 88
Kayembe, P. K., Goubau, P., Desmyter, J., VLIETINCK, R. F., & Carton, H. (1990) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.53.1.4 · Cited by 87
A neuropathic syndrome of uncertain origin: review of 100 cases.
Cruickshank, E. K. (1956) · PubMed · Cited by 86
KIR2DL2 Enhances Protective and Detrimental HLA Class I-Mediated Immunity in Chronic Viral Infection
al Basatena, N.-K. S., MacNamara, A., Vine, A. M., Thio, C. L., Astemborski, J. A., Usuku, K., Osame, M., Kirk, G. D., Donfield, S. M., Goedert, J. J., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002270 · Cited by 84
Self-citationProspective Study of HTLV-I Infection in an Initially Asymptomatic Cohort
Taylor, G. P., Tosswill, J. H. C., Matutes, E., Daenke, S., Hall, S., Bain, B. J., Davis, R., Thomas, D. J., Rossor, M. N., Bangham, C. R. M., et al. (1999) · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · doi:10.1097/00042560-199909010-00012 · Cited by 83
Self-citationToulza, F., Nosaka, K., Tanaka, Y., Schioppa, T., Balkwill, F. R., Taylor, G. P., & Bangham, C. R. M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903846 · Cited by 82
Self-citationThe prevalence of human T-cell lymphotropic virus type 1 in the general population is unknown.
Hlela, C., Shepperd, S., Khumalo, N. P., & Taylor, G. P. (2009) · PubMed · Cited by 81
Self-citationTsukasaki, K., & Tobinai, K. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0572 · Cited by 80
Neuropathology of HTLV‐1‐associated myelopathy (HAM/TSP)
Izumo, S. (2010) · Neuropathology · doi:10.1111/j.1440-1789.2010.01135.x · Cited by 76
Einsiedel, L. J., Spelman, T. D., Goeman, E., Cassar, O., Arundell, M., & Gessain, A. (2014) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002643 · Cited by 76
Asquith, B., & Bangham, C. R. M. (2007) · Immunology and Cell Biology · doi:10.1038/sj.icb.7100050 · Cited by 76
Self-citationFatigue in Multiple Sclerosis: A Look at the Role of Poor Sleep
Strober, L. B. (2015) · Frontiers in Neurology · doi:10.3389/fneur.2015.00021 · Cited by 76
Hieshima, K., Nagakubo, D., Nakayama, T., Shirakawa, A., Jin, Z. H., & Yoshie, O. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.2.931 · Cited by 75
Interferon‐β1a therapy in human T‐lymphotropic virus type I–associated neurologic disease
Oh, U., Yamano, Y., Mora, C. A., Ohayon, J., Bagnato, F., Butman, J. A., Dambrosia, J., Leist, T. P., McFarland, H., & Jacobson, S. (2005) · Annals of Neurology · doi:10.1002/ana.20429 · Cited by 74
Self-citationSpasticity - Pathogenesis, prevention and treatment strategies
Ghai, A., Garg, N., Hooda, S., & Gupta, T. (2013) · Saudi Journal of Anaesthesia · doi:10.4103/1658-354x.121087 · Cited by 73
Kaplan, J. E., Litchfield, B., Rouault, C., Lairmore, M. D., Luo, C.-C., Williams, L. H., Brew, B. J., Price, R. W., Janssen, R. S., Stoneburner, R. L., et al. (1991) · Neurology · doi:10.1212/wnl.41.2_part_1.192 · Cited by 72
Short-term breast-feeding may reduce the risk of vertical transmission of HTLV-I
Takezaki, T., Tajima, K., Ito, M., Ito, S.-I., Kinoshita, K., TACHIBANA, K., & Matsushita, Y. (1997) · Leukemia · Cited by 71
Matsuzaki, T., Saito, M., Usuku, K., Nose, H., Izumo, S., Arimura, K., & Osame, M. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.05.011 · Cited by 70
Toulza, F., Nosaka, K., Takiguchi, M., Pagliuca, T., Mitsuya, H., Tanaka, Y., Taylor, G. P., & Bangham, C. R. M. (2009) · International Journal of Cancer · doi:10.1002/ijc.24664 · Cited by 70
Self-citationMartin, F., Fedina, A., Youshya, S., & Taylor, G. P. (2010) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.191239 · Cited by 70
Self-citationCorticosteroid therapy in TSP/HAM patients: The results from a 10 years open cohort
Croda, M. G., de Oliveira, A. C. P., Vergara, M. P. P., Bonasser, F., Smid, J., Duarte, A. J. D. S., & Casseb, J. (2008) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.01.004 · Cited by 70
Human T cell Leukemia Virus Type I Infection and Chronic Myelopathy
Iwasaki, Y. (1993) · Brain Pathology · doi:10.1111/j.1750-3639.1993.tb00719.x · Cited by 69
Chang, Y. B., Kaidarova, Z., Hindes, D., Bravo, M. D., Kiely, N., Kamel, H. T., DuBay, D. A., Hoose, B., & Murphy, E. L. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit497 · Cited by 68
Takezaki, T., Tajima, K., Ito, M., Ito, S., Kinoshita, K., Tachibana, K., & Matsushita, Y. (1997) · PubMed · Cited by 68
Harrington, W. J., Sheremata, W. A., Snodgrass, S. R., Emerson, S., Phillips, S., & Berger, J. R. (1991) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1991.7.1031 · Cited by 67
Stem cell therapy for the spinal cord
Donnelly, E. M., Lamanna, J. J., & Boulis, N. M. (2012) · Stem Cell Research & Therapy · doi:10.1186/scrt115 · Cited by 67
Sabouri, A. H., Saito, M., Lloyd, A. L., Vine, A. M., Witkover, A., Furukawa, Y., Izumo, S., Arimura, K., Marshall, S. E., Usuku, K., et al. (2004) · The Journal of Infectious Diseases · doi:10.1086/423942 · Cited by 67
Self-citationHuman T-lymphotrophic virus type 1–associated infective dermatitis: A comprehensive review
Lee, R., & Schwartz, R. A. (2010) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2009.10.021 · Cited by 65
Virus Markers Associated with Vertical Transmission of Human T Lymphotropic Virus Type 1 in Jamaica
Hisada, M., Maloney, E. M., Sawada, T., Miley, W., Palmer, P., Hanchard, B., Goedert, J. J., & Manns, A. (2002) · Clinical Infectious Diseases · doi:10.1086/340537 · Cited by 63
Iwasaki, Y., Ohara, Y., Kobayashi, I., & Akizuki, S. (1992) · PubMed Central · Cited by 62
Journo, C., & Mahieux, R. (2011) · Viruses · doi:10.3390/v3081374 · Cited by 61
Tanaka, Y., Tanaka, R. J., Terada, E., Koyanagi, Y., Miyano‐Kurosaki, N., Yamamoto, N., Baba, E., Nakamura, M., & Shida, H. (1994) · Journal of Virology · doi:10.1128/jvi.68.10.6323-6331.1994 · Cited by 60
Hewitt, P. E., Davison, K. L., Howell, D. R., & Taylor, G. P. (2013) · Transfusion · doi:10.1111/trf.12105 · Cited by 60
Self-citationFranzoi, A. C., & Araújo, A. (2004) · Spinal Cord · doi:10.1038/sj.sc.3101677 · Cited by 57
Kinpara, S., Hasegawa, A., Utsunomiya, A., Nishitsuji, H., Furukawa, H., Masuda, T., & Kannagi, M. (2009) · Journal of Virology · doi:10.1128/jvi.02564-08 · Cited by 57
Yamasaki, K., Kira, J., Koyanagi, Y., Kawano, Y., Miyano‐Kurosaki, N., Nakamura, M., Baba, E., Suzuki, J., Yamamoto, A., Yamamoto, N., et al. (1997) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(96)05319-1 · Cited by 56
Feng, Y., Itoyama, Y., Fujihara, K., & Goto, I. (1991) · Journal of Neuroimmunology · doi:10.1016/0165-5728(91)90056-d · Cited by 55
PLASMAPHERESIS IN TREATMENT OF HUMAN T-LYMPHOTROPIC VIRUS TYPE-I ASSOCIATED MYELOPATHY
Matsuo, H., Tsujihata, M., Satoh, A., Shirabe, S., Nakamura, T., Kinoshita, I., Tomita, I., Shibayama, K., & Nagataki, S. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90525-9 · Cited by 55
Guerreiro, J. B., Santos, S., Morgan, D. J., Porto, A. F., Muniz, A. L., Ho, J. L., Teixeira, A. L., Teixeira, M. M., & Carvalho, E. M. (2006) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2006.03150.x · Cited by 54
Silva, M. T. T., Mattos, P., Alfano, A., & Araújo, A. Q.-C. (2003) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.8.1085 · Cited by 54
Overview on HTLV-1 p12, p8, p30, p13: accomplices in persistent infection and viral pathogenesis
Bai, X. T., & Nicot, C. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00400 · Cited by 53
Safety of long-term treatment of HAM/TSP patients with valproic acid
Olindo, S., Belrose, G., Gillet, N., Rodriguez, S., Boxus, M., Verlaeten, O., Asquith, B., Bangham, C., Signaté, A., Smadja, D., et al. (2011) · Blood · doi:10.1182/blood-2011-04-349910 · Cited by 52
Self-citationMacchi, B., Balestrieri, E., Ascolani, A., Hilburn, S., Martin, F., Mastino, A., & Taylor, G. P. (2011) · Viruses · doi:10.3390/v3050469 · Cited by 50
Self-citationAraújo, A., Leite, A. C. B., Dultra, S. V., & Andrada‐Serpa, M. J. (1995) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(94)00266-q · Cited by 49
Susceptibility of Human T Cell Leukemia Virus Type I to Nucleoside Reverse Transcriptase Inhibitors
Hill, S. A., Lloyd, P. A., McDonald, S. L., Wykoff, J., & Derse, D. (2003) · The Journal of Infectious Diseases · doi:10.1086/376531 · Cited by 49
Differential expression of interferon-γ receptor on human glial cells in vivo and in vitro
Hashioka, S., Klegeris, A., Schwab, C., Yu, S. Y., & McGeer, P. L. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.04.023 · Cited by 48
A Sero‐Epidemiological Study on Mother‐to‐Child Transmission of HTLV‐I in Southern Kyushu, Japan*
Oki, T., Yoshinaga, M., Otsuka, H., Miyata, K., Sonoda, S., & Nagata, Y. (1992) · Asia-Oceania Journal of Obstetrics and Gynaecology · doi:10.1111/j.1447-0756.1992.tb00333.x · Cited by 48
Sonoda, J., Koriyama, C., Yamamoto, S., Kozako, T., Li, H. C., Lema, C., Yashiki, S., Fujiyoshi, T., Yoshinaga, M., Nagata, Y., et al. (2004) · Cancer Science · doi:10.1111/j.1349-7006.2004.tb02493.x · Cited by 46
Oliveira, P., de Castro, N. M., Muniz, A. L., Costa, D. T., Brandão, J. C. F., Porto, A. F., & Carvalho, E. M. (2010) · Urology · doi:10.1016/j.urology.2009.11.041 · Cited by 46
Neuropathology of HTLV‐I‐Associated Myelopathy—A Report of Two Autopsy Cases—
Izumo, S., Ijichi, T., Higuchi, I., Tashiro, A., Takahashi, K., & Osame, M. (1992) · Pediatrics International · doi:10.1111/j.1442-200x.1992.tb00972.x · Cited by 46
Saito, M., Braud, V. M., Goon, P. K. C., Hanon, E., Taylor, G. P., Saito, A., Eiraku, N., Tanaka, Y., Usuku, K., Weber, J. N., et al. (2003) · Blood · doi:10.1182/blood-2002-09-2855 · Cited by 45
Self-citationUmehara, F., Nose, H., Saito, M., Fukuda, M., Ogino, M., Toyota, T., Yuhi, T., Arimura, K., & Osame, M. (2007) · Journal of NeuroVirology · doi:10.1080/13550280701258431 · Cited by 43
Yamauchi, J., Coler-Reilly, A. L. G., Sato, T., Araya, N., Yagishita, N., Ando, H., Kunitomo, Y., Takahashi, K., Tanaka, Y., Shibagaki, Y., et al. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu438 · Cited by 43
Self-citationRomanelli, L. C. F., Caramelli, P., Martins, M. L., Gonçalves, D. U., Proietti, F. A., Ribas, J. G., Araújo, M. G., & Carneiro‐Proietti, A. B. F. (2013) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2013.0086 · Cited by 42
Intermittent high-dose vitamin C therapy in patients with HTLV-I associated myelopathy.
Kataoka, A., Imai, H., Inayoshi, S., & Tsuda, T. (1993) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.56.11.1213 · Cited by 39
Netto, E. C., & Brites, C. R. (2010) · Clinical Journal of Pain · doi:10.1097/ajp.0b013e3181f195d3 · Cited by 39
Gender influence on the progression of HTLV-I associated myelopathy/tropical spastic paraparesis
Lima, M. A., Bica, R. B. S., & Araújo, A. Q. C. (2005) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.035709 · Cited by 39
Cachat, A., Chevalier, S. A., Alais, S., Ko, N. L., Ratner, L., Journo, C., Dutartre, H., & Mahieux, R. (2013) · Journal of Virology · doi:10.1128/jvi.02758-13 · Cited by 39
Martin, F., Castro, H., Gabriel, C., Adonis, A., Fedina, A., Harrison, L., Brodnicki, L., Demontis, M. A., Babiker, A. G., Weber, J. N., et al. (2012) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0001675 · Cited by 38
Self-citationNarikawa, K., Fujihara, K., Misu, T., Feng, J., Fujimori, J., Nakashima, I., Miyazawa, I., Saito, H., Sato, S., & Itoyama, Y. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.10.011 · Cited by 37
Talledo, M., López, G., Huyghe, J. R., Verdonck, K., Adaui, V., González, E., Best, I., Clark, D. L., Vanham, G., Gotuzzo, E., et al. (2010) · Journal of Medical Virology · doi:10.1002/jmv.21675 · Cited by 37
Diagnosis of HAM/TSP based on CSF proviral HTLV-I DNA and HTLV-I antibody index
Puccioni‐Sohler, M., Rios, M., de Carvalho, S. M. F., Rr, G., Oliveira, C., Corrêa, R. B., Novis, S. A. P., Pombo‐de‐Oliveira, M. S., & Bianco, C. (2001) · Neurology · doi:10.1212/wnl.57.4.725 · Cited by 37
The roles of acquired and innate immunity in human T-cell leukemia virus type 1-mediated diseases
Kannagi, M., Hasegawa, A., Takamori, A., Kinpara, S., & Utsunomiya, A. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00323 · Cited by 36
Assone, T., de Souza, F. V., Gaester, K. E. D. O., Fonseca, L. A. M., Luiz, O. D. C., Malta, F. D. M., Pinho, J. R. R., Gonçalves, F. D. T., Duarte, A. J. D. S., de Oliveira, A. C. P., et al. (2014) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003199 · Cited by 34
Quality of life in patients with HTLV-I associated myelopathy/tropical spastic paraparesis
Martins, J. V., Baptista, A. F., & Araújo, A. (2012) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x2012005000006 · Cited by 34
Catalan-Soares, B. C., Carneiro‐Proietti, A. B. F., da Fonseca, F. G., Corrêa‐Oliveira, R., Peralva-Lima, D., Portela, R., Ribas, J. G., Gonçalves, D. U., & Proietti, F. A. (2008) · Medical Microbiology and Immunology · doi:10.1007/s00430-008-0096-z · Cited by 34
Fujihara, K., Itoyama, Y., Feng, Y., Kubo, C., & Goto, I. (1991) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(91)90125-q · Cited by 34
Moens, B., Decanine, D., Menezes, S. M., Khouri, R., Silva-Santos, G., López, G., Álvarez, C., Talledo, M., Gotuzzo, E., Kruschewsky, R. D. A., et al. (2012) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0001729 · Cited by 31
Yukitake, M., Sueoka, E., Sueoka‐Aragane, N., Sato, A., Ohashi, H., Yakushiji, Y., Saito, M., Osame, M., Izumo, S., & Kuroda, Y. (2008) · Journal of NeuroVirology · doi:10.1080/13550280701883840 · Cited by 31
Arimura, K., Nakagawa, M., Izumo, S., Usuku, K., Itoyama, Y., Kira, J.-I., & Osame, M. (2007) · Journal of Neurovirology · doi:10.1080/13550280701397627 · Cited by 31
Association between HLA alleles and HAM/TSP in individuals infected with HTLV-1
Treviño, A., Vicario, J. L., López, M., Parra, P., Benito, R., de Lejarazu, R. O., Ramos, J. M., Romero, J., de Mendoza, C., & Soriano, V. (2013) · Journal of Neurology · doi:10.1007/s00415-013-7014-z · Cited by 29
Imaging of human T-lymphotropic virus type I-associated chronic progressive myeloneuropathies
Alcindor, E., Valderrama, R., Canavaggio, M., Lee, H., Katz, A. S., Montesinos, C., Madrid, R. E., Merino, R. R., & Pipia, P. A. (1992) · Neuroradiology · doi:10.1007/bf00588283 · Cited by 29
Lima, M. A., Harab, R. C., Schor, D., Andrada‐Serpa, M. J., & Araújo, A. (2007) · Journal of NeuroVirology · doi:10.1080/13550280701510096 · Cited by 28
Successful application of pentoxifylline in the treatment of HTLV-I associated myelopathy
Shirabe, S., Nakamura, T., Tsujino, A., Nishiura, Y., Furuya, T., Goto, H., Suenaga, A., Nakane, S., Yoshimura, T., & Nagataki, S. (1997) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(97)00074-9 · Cited by 28
Familial Clusters of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
Nozuma, S., Matsuura, E., Matsuzaki, T., Watanabe, O., Kubota, R., Izumo, S., & Takashima, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086144 · Cited by 28
Yukitake, M., Takase, Y., Nanri, Y., Kosugi, M., Eriguchi, M., Yakushiji, Y., Okada, R., Mizuta, H., & Kuroda, Y. (2008) · Internal Medicine · doi:10.2169/internalmedicine.47.1284 · Cited by 28
Implications of HAM/TSP functional incapacity in the quality of life
Shublaq, M., Orsini, M. A., & Puccioni‐Sohler, M. (2011) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x2011000200013 · Cited by 27
Hodson, A., Laydon, D. J., Bain, B. J., Fields, P. A., & Taylor, G. P. (2012) · Haematologica · doi:10.3324/haematol.2012.069476 · Cited by 27
Self-citationProspects for the management of human T-cell lymphotropic virus type 1-associated myelopathy.
Martin, F., & Taylor, G. P. (2011) · PubMed · Cited by 27
Self-citationGadelha, S. R., Alcântara, L. C. J., Costa, G. C., Acosta, A. X., Rios, D. L. S., Kashima, S. H., Covas, D. T., & Galvão‐Castro, B. (2008) · Journal of Medical Virology · doi:10.1002/jmv.21341 · Cited by 26
Sacher, R. A., Luban, N. L. C., Ameti, D. I., Friend, S., Schreiber, G. B., Murphy, E. L., & for the Retrovirus Epidemiology Donor Study Group (REDS) (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01408.x · Cited by 25
Systemic interferon-alpha in the treatment of HTLV-I-associated myelopathy
Kuroda, Y., Kurohara, K., Fujiyama, F., Takashima, H., Endo, C., Matsui, M., Neshige, R., & Kakigi, R. (1992) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1992.tb08059.x · Cited by 25
Ozden, S., Seilhean, D., Gessain, A., Hauw, J., & Gout, O. (2002) · Clinical Infectious Diseases · doi:10.1086/338868 · Cited by 24
Saito, M., Tanaka, R., Fujii, H., Kodama, A., Takahashi, Y., Matsuzaki, T., Takashima, H., & Tanaka, Y. (2014) · Retrovirology · doi:10.1186/s12977-014-0074-z · Cited by 24
Plasma proteome analysis in HTLV-1-associated myelopathy/tropical spastic paraparesis
Kirk, P., Witkover, A., Courtney, A. P., Lewin, A., Wait, R., Stumpf, M. P. H., Richardson, S. T., Taylor, G. P., & Bangham, C. R. M. (2011) · Retrovirology · doi:10.1186/1742-4690-8-81 · Cited by 23
Self-citationDo T cells cause HTLV-1-associated disease?: a taxing problem
Daenke, S., & Bangham, C. R. M. (1994) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1994.tb06538.x · Cited by 22
Self-citationNakamura, T., Matsuo, T., Fukuda, T., Yamato, S., Yamaguchi, K., Kinoshita, I., Matsuzaki, T., Nishiura, Y., Nagasato, K., Narita-Masuda, T., et al. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-182 · Cited by 22
Pain in tropical spastic paraparesis/HTLV-I associated myelopathy patients
de Castro‐Costa, C. M., Araújo, A., da Camara, C. C., Ferreira, A. S., Santos, T. D. J. T., Costa, S. B. D. C., Alcântara, R. N. M., & Taylor, G. P. (2009) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x2009000500016 · Cited by 21
Self-citationHuman T-lymphotropic virus 1 neurologic disease
Araújo, A., Lima, M. A., & Silva, M. T. T. (2008) · Current Treatment Options in Neurology · doi:10.1007/s11940-008-0021-1 · Cited by 20
de Britto, V. L. S., Corrêa, R. B., & Vincent, M. B. (2014) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/0037-8682-0245-2013 · Cited by 19
Nose, H., Saito, M., Usuku, K., Sabouri, A. H., Matsuzaki, T., Kubota, R., Eiraku, N., Furukawa, Y., Izumo, S., Arimura, K., et al. (2006) · Journal of NeuroVirology · doi:10.1080/13550280600827336 · Cited by 16
Deschamps, R., Béra, O., Belrose, G., Lézin, A., Bellance, R., Signaté, A., Cabre, P., Smadja, D., Césaire, R., & Olindo, S. (2010) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2010.05.020 · Cited by 16
Chronic progressive cervical myelopathy with HTLV-I infection: Variant form of HAM/TSP?
Umehara, F., Nagatomo, S., Yoshishige, K., Saito, M., Furukawa, Y., Usuku, K., & Osame, M. (2004) · Neurology · doi:10.1212/01.wnl.0000140496.03342.bc · Cited by 16
Nagasato, K., Nakamura, T., Ichinose, K., Nishiura, Y., Ohishi, K., Shibayama, K., Watanabe, H., Tsujihata, M., & Nagataki, S. (1993) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(93)90220-s · Cited by 14
Nakamura, T., Satoh, K., Fukuda, T., Kinoshita, I., Nishiura, Y., Nagasato, K., Yamauchi, A., Kataoka, Y., Nakamura, T., Sasaki, H., et al. (2014) · Journal of NeuroVirology · doi:10.1007/s13365-014-0244-8 · Cited by 13
Danazol a new perspective in the treatment of htlv-l associated myelopathy (preliminary report)
Melo, A., Moura, L., Meireles, A., & Costa, G. (1992) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x1992000300025 · Cited by 12
Treatment of patients with HTLV-1-associated myelopathy with methotrexate
Ahmed, S., Adonis, A., Hilburn, S., Demontis, M., Fedina, A., Haddow, J., Gabriel, C. M., Fidler, S. J., & Taylor, G. (2014) · Retrovirology · doi:10.1186/1742-4690-11-s1-p33 · Cited by 6
Self-citation
Cited by
Viruses and Autoimmunity: A Review on the Potential Interaction and Molecular Mechanisms
Smatti, M. K., Cyprian, F. S., Nasrallah, G. K., Al Thani, A. A., Almishal, R. O., & Yassine, H. M. (2019) · Viruses · doi:10.3390/v11080762 · Cited by 544
Futsch, N., Mahieux, R., & Dutartre, H. (2017) · Viruses · doi:10.3390/v10010001 · Cited by 155
Reducing the global burden of HTLV-1 infection: An agenda for research and action
Willems, L., Hasegawa, H., Accolla, R., Bangham, C., Bazarbachi, A., Bertazzoni, U., Carneiro-Proietti, A. B. D. F., Cheng, H., Chieco-Bianchi, L., Ciminale, V., et al. (2017) · Antiviral Research · doi:10.1016/j.antiviral.2016.10.015 · Cited by 140
Self-citationMogamulizumab (Anti-CCR4) in HTLV-1-Associated Myelopathy
Sato, T., Coler-Reilly, A. L. G., Yagishita, N., Araya, N., Inoue, E., Furuta, R., Watanabe, T., Uchimaru, K., Matsuoka, M., Matsumoto, N., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1704827 · Cited by 113
Self-citationHuman T-cell leukemia virus type 1 infects multiple lineage hematopoietic cells in vivo
Furuta, R., Yasunaga, J.-I., Miura, M., Sugata, K., Saito, A., Akari, H., Ueno, T., Takenouchi, N., Fujisawa, J.-I., Koh, K.-R., et al. (2017) · PLOS Pathogens · doi:10.1371/journal.ppat.1006722 · Cited by 83
Self-citation
Metadata
- Authors
- Bangham, C. R. M., Araujo, A., Yamano, Y., & Taylor, G. P.
- Venue
- Nature Reviews Disease Primers
- Published
- 2015-06-18
- Volume
- 1
- Issue
- 1
- Pages
- 15012-15012
- ISSN
- 2056-676X (ISSN-L)
- OpenAlex
- W2402954627
- Cited by
- 279
- References
- 196
- FWCI
- 0.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.